Gal(b1-4)Man
In Stock•Starting at $58 for 5 mg•Purity ≥ 98%
| CAS No. | 20869-27-6 |
|---|---|
| MDL No. | N/A |
| MF | C12H22O11 |
| MW | 342.30 |
| InChI Key | GUBGYTABKSRVRQ-GAQSDDIXSA-N |
| CAS No. | 20869-27-6 |
|---|---|
| MDL No. | N/A |
| MF | C12H22O11 |
| MW | 342.30 |
| InChI Key | GUBGYTABKSRVRQ-GAQSDDIXSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 5 mg | 98% | $58 | In Stock | |
| 10 mg | 98% | $85 | In Stock | |
| 25 mg | 98% | $167 | In Stock | |
| 50 mg | 98% | $266 | In Stock | |
| 100 mg | 98% | $397 | In Stock | |
| 250 mg | 98% | $790 | In Stock | |
| 1 g | 98% | $3089 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Beta-D-Gal-(1->4)-D-Man is a glycosylmannose consisting of a beta-D-galactopyranose unit linked via (1->4) to D-mannopyranose, and it inhibits Leishmania major glycoinositol phospholipid binding by sera from patients with acute cutaneous leishmaniasis.
| CAS No. | 20869-27-6 |
|---|---|
| Product Name | Gal(b1-4)Man |
| Heavy Atom Count | 23 | Rotatable Bond Count | 4 |
| Atom Stereo Count | 10 | Bond Stereo Count | 0 |
| HBA | 11 | HBD | 8 |
| TPSA | 189.530 Ų | Charge | 0 |
| Exact Mass | 342.11621 | Complexity | 378.02 |
| pKa | 11.080 | XLogP | -5.397 |